Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab
Clinical trial NCT04677361 · WITHDRAWN
Trial details
- NCT number
- NCT04677361
- Sponsor
- Fox Chase Cancer Center
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2023-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.